SCOTUS: Abortion Rights, Roe Vs, Wade, Food and Drug Administration ACCESS to Mifepristone
March 26, 2024
10,130
63
89
1.50%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
The Hill Episodes Around March 26, 2024
See what was published immediately before and after this episode.
10:49Robby Soave: NBC’s FREAKOUT Over Ronna McDaniel Exposes Media HYPOCRISY
2:36Now PlayingSCOTUS: Abortion Rights, Roe Vs, Wade, Food and Drug Administration ACCESS to Mifepristone
YouTube Description
as posted by the channelA fight over abortion pills at the Supreme Court this week could have sweeping consequences for all Americans’ access to mifepristone, even those who live in blue states.
Abortion will be back in court Tuesday, when the same justices who overturned Roe v. Wade will hear arguments about whether federal regulators overstepped their authority by loosening restrictions to make mifepristone easier to access.
Mifepristone, which is sold both under the brand name Mifeprex and as a generic drug, is commonly used with one other drug during medication abortions. The stakes of the case were made clear this week when new data showed more than 60 percent of all abortions last year were done through medication.
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.